Literature DB >> 15246320

Intravascular schistosomes and complement.

Patrick J Skelly1.   

Abstract

Schistosomes are exposed to a variety of immunological effectors, such as host complement, in the bloodstream of their definitive hosts. The parasites are reported to possess a plethora of regulatory proteins, including molecules acquired from the host, which impede the complement cascade. Evidence for the presence of a surface C2-binding protein, a C3-binding protein and a C8- and C9-binding protein has been reported. In addition, a surface Fc receptor might bind immunoglobulin and limit its ability to fix complement. However, the actual protective role of these proteins in vivo remains unresolved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246320     DOI: 10.1016/j.pt.2004.05.007

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  12 in total

1.  How schistosomes alter the human serum proteome.

Authors:  Akram A Da'dara; Giles Siddons; Melissa Icaza; Qiang Wang; Patrick J Skelly
Journal:  Mol Biochem Parasitol       Date:  2016-12-21       Impact factor: 1.759

2.  Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats.

Authors:  Jorge Sepulveda; Jacqueline M Tremblay; Jon P DeGnore; Patrick J Skelly; Charles B Shoemaker
Journal:  Int J Parasitol       Date:  2010-06-30       Impact factor: 3.981

Review 3.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

4.  Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis.

Authors:  C Lochmatter; C L Schneider; K Ingram; J Keiser; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

5.  On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.

Authors:  Leonardo P Farias; Greice Krautz-Peterson; Cibele A Tararam; Bogar O Araujo-Montoya; Tatiana R Fraga; Henrique K Rofatto; Floriano P Silva; Lourdes Isaac; Akram A Da'dara; R Alan Wilson; Charles B Shoemaker; Luciana C C Leite
Journal:  PLoS Negl Trop Dis       Date:  2013-10-24

6.  Characterization of Schistosoma japonicum tetraspanning orphan receptor and its role in binding to complement C2 and immunoprotection against murine schistosomiasis.

Authors:  Shuai Ma; Jinli Zai; Yanhui Han; Yang Hong; Min Zhang; Xiaodan Cao; Qian Han; Ke Lu; Zhixin Zhao; Jiaojiao Lin; Zhiqiang Fu
Journal:  Parasit Vectors       Date:  2017-06-09       Impact factor: 3.876

Review 7.  Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPMPZQ by PZQ, enhanced Ca++ influx, spastic paralysis, and tegumental disrupture-the deadly cascade in parasitic schistosomes, other trematodes, and cestodes.

Authors:  Achim Harder
Journal:  Parasitol Res       Date:  2020-06-30       Impact factor: 2.289

Review 8.  Behind Enemy Lines: Immunomodulatory Armamentarium of the Schistosome Parasite.

Authors:  Jose Ma M Angeles; Van Jerwin P Mercado; Pilarita T Rivera
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

9.  Novel scabies mite serpins inhibit the three pathways of the human complement system.

Authors:  Angela Mika; Simone L Reynolds; Frida C Mohlin; Charlene Willis; Pearl M Swe; Darren A Pickering; Vanja Halilovic; Lakshmi C Wijeyewickrema; Robert N Pike; Anna M Blom; David J Kemp; Katja Fischer
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

10.  Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.

Authors:  Gordana Panic; Marie-Thérèse Ruf; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.